Analyses of cytokines in the ischemic hemisphere at 2d post-stroke showed that only one pro-inflammatory cytokine, IL-18, was affected by post-stroke NaB treatment (Fig. 6c, 611.1 ± 34.12 pg/mg protein vs. 515.1 ± 30.23 pg/mg protein, p = 0.0467, n = 12/group), while IL-1beta (Fig. 6a, 69.86 ± 9.58 pg/mg protein vs. 74.73 ± 12.48 pg/mg protein, p = 0.7598, n = 12/group) and IL-17A (Fig. 6b, 67.62 ± 6.05 pg/mg protein vs. 67.51 ± 6.31 pg/mg protein, p = 0.9902, n = 11-12/group) were not affected. The gene discussed is IL1B; the disease is stroke disorder.